Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
about
Animal Models for HIV Cure ResearchConsiderations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategiesPersistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplantResidual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolutionAnimal models for HIV/AIDS researchProphylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaquesViral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDSEnhanced antiretroviral therapy in rhesus macaques improves RT-SHIV viral decay kineticsHigh natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.Nonhuman primate models for HIV cure research.A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAARTMass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirsHIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcriptionSequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal.Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase.Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Experimental approaches to the study of HIV-1 latency.Macaque models of human infectious disease.Antiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS PathogenesisNonhuman primate models of NeuroAIDSSuppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gaRT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.Variation of human immunodeficiency virus type-1 reverse transcriptase within the simian immunodeficiency virus genome of RT-SHIV.HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factorsLatest animal models for anti-HIV drug discovery.Tackling HIV and AIDS: contributions by non-human primate models.Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency.Quantifying integrated SIV-DNA by repetitive-sampling Alu-gag PCR.A quantitative measurement of antiviral activity of anti-human immunodeficiency virus type 1 drugs against simian immunodeficiency virus infection: dose-response curve slope strongly influences class-specific inhibitory potentialNonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review.
P2860
Q26767476-8510DA3A-24B0-4719-B595-927D12985D5BQ26825814-202481AE-7626-4CBC-B728-613428F967C1Q27323780-5B0EEA0B-98BE-46B8-8A43-6429022956D4Q28539563-463CDF3B-05EF-4D4D-A4D6-E5EEAF0634A6Q30423656-DC5DB7C0-DEA7-4049-B93E-4722E2D6BEA1Q33592750-1D10083F-1AA8-4BF5-A15F-281782F61771Q33644248-8767CA68-D55F-4E41-9986-38B1B166B9E1Q33676630-77182253-E00F-452C-A443-619A9DAF4E87Q33798207-A2E8669A-E9DD-40F9-99DC-27038EF31268Q34291018-0A719956-A6F8-4D6B-BC0E-7CF0670C08F4Q34407781-9D3E01C1-F561-40C6-B6D9-A3752850F4BFQ34990151-B1B106E9-A1F7-45D1-AC65-07AD83E19958Q35088292-41763E7F-9A03-4245-A29B-E4B871335C9BQ35385971-49F8FDBD-414C-4659-9AFF-AFF16D3EC3ECQ35612098-6391D6D6-B268-4163-B11C-B7AF21FAF9F5Q35752812-0D17A965-41DE-4D9A-A0A8-AEB6D02C75F7Q36164175-14F1108E-71F4-4A2D-AF19-E14D50A742B3Q36290753-DC21E75A-E56B-41CE-85D9-1CFF9AE47E44Q36315555-74D3E306-DBCF-4317-9B27-5C3F5EE3B6B5Q36537806-F5541F5C-8C82-4A28-9D34-C5BA80BBA082Q36708954-045486CC-8D60-425B-B140-D5C4DC7243C4Q37103536-6E86A41D-0166-4BEB-BE5A-E86D2752BFFCQ37174423-0A2FE89C-24B3-4C3F-BD43-7FE6FFDAD801Q37264017-2E21637A-D3BD-4CB7-8A1F-E2039B640772Q37275103-FA4E5786-A858-4E96-9181-031F6302F26CQ37428359-2DE65BD0-4232-4CC5-9190-E6DBE6D1AA85Q37538534-D30FA872-A219-468D-BDA0-470E49EFDC09Q37607912-7B0A9440-B926-450D-AF96-8A2402CB736CQ38121073-EB6FAE34-935D-426C-B27C-697B56206166Q38263295-AD616B6F-947B-4118-BB96-539AB5650600Q40191155-B99C48F3-CCB1-4CFE-A98C-6B1C2D53B993Q42200917-65A3C133-241B-41B2-83D6-34EEE5ED97BCQ42380885-8192B023-6268-4B90-B728-9338C52F94D1Q42701528-82AFA379-1468-4B26-BFEC-60FC96EB4472Q45326424-3A3ECD35-CBDF-4FF2-94E5-D379DEFAC4C8Q54942553-9F474C02-2F7D-43D6-8C7B-B4E6E3B39B6F
P2860
Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Suppression of virus load by h ...... immunodeficiency virus type 1.
@en
type
label
Suppression of virus load by h ...... immunodeficiency virus type 1.
@en
prefLabel
Suppression of virus load by h ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1433
P1476
Suppression of virus load by h ...... immunodeficiency virus type 1.
@en
P2093
Debra A Wadford
Joanne Higgins
Koen K A Van Rompay
Niels C Pedersen
Thomas W North
Timothy B Matthews
P2860
P304
P356
10.1128/JVI.79.12.7349-7354.2005
P577
2005-06-01T00:00:00Z